I love to utilize my basic and translational science capabilities to develop new technologies, medicines, and modalities to the real world to save lives. Detail-oriented team player with strong organizational skills. Ability to handle multiple projects simultaneously with a high degree of accuracy.
Assay development
undefined1. Narayan C, Veeramani S, Thiel WH. Optimization of RNA Aptamer SELEX Methods: Improved Aptamer Transcript 3'-End Homogeneity, PAGE Purification Yield, and Target-Bound Aptamer RNA Recovery. Nucleic Acid Ther. 2022 Feb;32(1):74-80. doi: 10.1089/nat.2021.0060. Epub 2021 Nov 10. PMID: 34757856; PMCID: PMC8817694.
2. Narayan C, Kwon J, Kim C, Kim SJ, Jang SK. Virus-based SELEX (viro-SELEX) allows development of aptamers targeting knotty proteins. Analyst. 2020 Feb 17;145(4):14731482. PubMed PMID: 31868873.
3. Kwon J, Narayan C, Kim C, Han MJ, Kim M, Jang SK. Development of a SubtypeSpecific Diagnostic System for Influenza Virus H3N2 Using a Novel Virus-Based Systematic Evolution of Ligands by Exponential Enrichment (Viro-SELEX). J Biomed Nanotechnol. 2019 Jul 1;15(7):1609-1621. PubMed PMID: 31196363.
4. Raghavendra Achar VG et.al. Optimization of Compound Plate Preparation to Address Precipitation Issue in Mammalian A549 Cytotoxicity Assay. J Lab Autom. 2016 Jun;21(3):423-31. PubMed PMID: 26185254.
5. Sharma S et.al. Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2014 Oct;58(10):5801-8. PubMed Central PMCID: PMC4187967.
6. Naik M et.al. 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity. Journal of Medicinal Chemistry. 2014 June 11; 57(12):5419-5434. PubMed PMID: 24871036
7. Shirude PS et.al. Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis. ACS Chem Biol. 2013 Mar 15;8(3):519-23. PubMed PMID: 23268609.
1. Presented my findings titled "Development of Rapid Influenza Diagnostic Test (RIDT) using aptamers" at Oligo therapeutics society 2017 meeting in Bordeaux, France as a poster.
2. Presented my findings titled “Virus–based SELEX (viro-SELEX) allows development of aptamers targeting knotty proteins” at Aptamers in Russia, 2019, Krasnoyarsk as oral talk.